Tasigna® (Nilotinib), a popular drug used to treat chronic myeloid leukemia, has been found to pose life-threatening risks to patients. Specifically, Tasigna causes severe and rapid-onset atherosclerosis which in turn causing peripheral arterial disease. On simple terms, Tasigna results in a swelling of the arteries which can lead to cardiovascular problems, limb amputation, and death. Intended to provide treatment for chronic leukemia, Tasigna in fact introduces a new and significant danger.
TASIGNA + ATHEROSCLEROSIS
The manufacturer, Novartis, has been aware of the risk for severe Tasigna side effects for several years; instead of warning consumers, the company aggressively marketed its product as superior to other treatments. Numerous studies have alleged that the drug Tasigna has serious undisclosed side effects that include irreversible and life threatening conditions, such as atherosclerosis, that can result in the following:
- ARM AMPUTATION
- LEG AMPUTATION
- SUDDEN DEATH
- SERIOUS INFECTIONS
- BLOCKED ARTERIES
- SERIOUS CARDIOVASCULAR ISSUES
DO YOU HAVE QUESTIONS ABOUT INJURIES RELATED TO TASIGNA?
If you or a loved one have been affected by the drug Tasigna, we encourage you to consult with our team as soon as possible. With our extensive knowledge and expertise, you can rest assured that should you choose to work with us, you will have legal representation that you can trust. All initial consultations are free, and we don’t charge any up-front fees for representation. We handle all fees on a contingency basis, meaning that unless we’re successful, you don’t have to pay us. Please contact Fulmer Sill at (405)510.0077 for a free consultation.